| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |